Literature DB >> 23921529

Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus?. Concerning the article by M.Y. Oncel et al: intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants [Neonatology 2013;103:166-169].

Serdar Alan1, Dilek Kahvecioglu, Omer Erdeve, Begum Atasay, Saadet Arsan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23921529     DOI： 10.1159/000352068

Source DB:  PubMed          Journal:  Neonatology        ISSN： 1661-7800            Impact factor:   4.035


× No keyword cloud information.
  13 in total

1.  Paracetamol treatment of patent ductus arteriosus in preterm infants.

Authors:  E Nadir; E Kassem; S Foldi; A Hochberg; M Feldman
Journal:  J Perinatol       Date:  2014-05-22       Impact factor: 2.521

2.  Intravenous paracetamol for PDA closure in the preterm: a single-center experience.

Authors:  Enrico Valerio; Marta Rossella Valente; Sabrina Salvadori; Anna Chiara Frigo; Eugenio Baraldi; Paola Lago
Journal:  Eur J Pediatr       Date:  2016-05-05       Impact factor: 3.183

3.  Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.

Authors:  Abd El-Rahman El-Mashad; Heba El-Mahdy; Doaa El Amrousy; Marwa Elgendy
Journal:  Eur J Pediatr       Date:  2016-12-21       Impact factor: 3.183

Review 4.  Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus.

Authors:  Mehmet Yekta Oncel; Omer Erdeve
Journal:  World J Clin Pediatr       Date:  2016-02-08

5.  Oral Paracetamol for Patent Ductus Arteriosus Rescue Closure.

Authors:  Pramod Pharande; Hadley Watson; Kenneth Tan; Arvind Sehgal
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

6.  Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol.

Authors:  Ana García-Robles; Ana Gimeno Navarro; María Del Mar Serrano Martín; María José Párraga Quiles; Anna Parra Llorca; José Luis Poveda-Andrés; Máximo Vento Torres; Marta Aguar Carrascosa
Journal:  Front Pediatr       Date:  2020-07-17       Impact factor: 3.418

Review 7.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

8.  Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies.

Authors:  Afif El-Khuffash; Amish Jain; David Corcoran; Prakesh S Shah; Christopher W Hooper; Naoko Brown; Stanley D Poole; Elaine L Shelton; Ginger L Milne; Jeff Reese; Patrick J McNamara
Journal:  Pediatr Res       Date:  2014-06-18       Impact factor: 3.756

Review 9.  Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?

Authors:  Flaminia Bardanzellu; Paola Neroni; Angelica Dessì; Vassilios Fanos
Journal:  Biomed Res Int       Date:  2017-07-30       Impact factor: 3.411

10.  Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates.

Authors:  Gianluca Terrin; Francesca Conte; Antonella Scipione; Erica Bacchio; Maria Giulia Conti; Rosalia Ferro; Flavia Ventriglia; Mario De Curtis
Journal:  Ital J Pediatr       Date:  2014-02-20       Impact factor: 2.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.